தாளம் பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தாளம் பலகை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தாளம் பலகை Today - Breaking & Trending Today

iRhythm® Technologies Announces Leadership Transition


iRhythm® Technologies Announces Leadership Transition
June 01, 2021 16:05 ET
| Source:
iRhythm
iRhythm
President and CEO Michael Coyle Steps Down Due to Personal Matters
Douglas Devine to Serve as Interim CEO While Search for Permanent CEO is Conducted
SAN FRANCISCO, June 01, 2021 (GLOBE NEWSWIRE) iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Mike Coyle has decided to resign from his position as President and Chief Executive Officer and a member of the Company’s Board of Directors, effective June 1, 2021, due to personal matters. Douglas Devine, the Company’s Chief Financial Officer, has assumed the role of interim CEO while a search for a permanent CEO is conducted. The iRhythm Board of Directors has formed a CEO search committee and has retained a leading executive search firm to assist in the search proces ....

United States , Mike Coyle , Abhijit Talwalkar , Douglas Devine , Exchange Commission On , Company Board Of Directors , Rhythm Technologies Inc , University Of Michigan , Centers For Medicare , Securities Exchange , Medicaid Services , Coyle Steps Down Due , Rhythm Technologies , Chief Executive Officer , Chief Financial Officer , Rhythm Board , Medicare Administrative Contractors , Chief Financial , Senior Vice President , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Exchange Commission , Nasdaq Irtc , ஒன்றுபட்டது மாநிலங்களில் , மைக் கோய்ல் ,

Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors


News Category Global Banking & Finance Reviews
Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors
Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors
BOSTON, Dec. 11, 2020 Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced the appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors.
“I am thrilled to welcome both Camille and Lynn to our Board of Directors, as both leaders have tremendous experience building and leading teams that work effectively to bring new medicines to patients in need,” said David Meeker, M.D., Chair, President and Chief Executive Officer of Rhythm.  ....

United States , Massachusetts Institute Of Technology , Harvard University , Lynn Tetrault , Lynna Tetrault , David Meeker , Camillel Bedrosian , Development Department Of Genetics Institute Inc , Hannah Deresiewicz Stern Investor Relations Inc , Clinical Research , University Of Virginia , Global Clinical Development , Rhythm Pharmaceuticals , Simmons University Institute For Inclusive Leadership , Princeton University , Harvard Medical School , Adam Daley Berry Company Public Relations , Alexion Pharmaceuticals Inc , Exchange Commission , Corporate Communications Rhythm Pharmaceuticals Inc , Rhythm Pharmaceuticals Inc , Duke Comprehensive Cancer Center , Corporate Affairs , Chief Executive Officer , Chief Medical Officer , Ultragenyx Pharmaceutical ,